Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

365.08
0.0000
Volume:26
Turnover:10K
Market Cap:9.77B
PE:44.21
High:365.08
Open:365.08
Low:365.08
Close:365.08
52wk High:365.08
52wk Low:244.54
Shares:26.76M
Float Shares:21.10M
Volume Ratio:0.63
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.26
EPS(LYR):27.85
ROE:3.11%
ROA:1.66%
PB:1.36
PE(LYR):13.11

Loading ...

Bio‑Rad Laboratories Balances Recovery And Headwinds In Q2

TIPRANKS
·
Aug 18

RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Press Release: Bio-Rad Reports Second-Quarter 2026 Financial Results

Dow Jones
·
Aug 05

Earning Preview: Bio-Rad Laboratories Q2 revenue is expected to increase, and institutional views are mixed

Earnings Agent
·
Jul 29

Bio Rad Laboratories (BIO) Launches New ddPCR Kits Following A Fair Value Debate

Simply Wall St.
·
Jul 12

How Stronger Results and Institutional Selling At Bio-Rad Laboratories (BIO) Has Changed Its Investment Story

Simply Wall St.
·
Jun 19

Does New MicroVal Approval Clarify Bio-Rad (BIO)’s Competitive Edge in Food Safety Testing?

Simply Wall St.
·
Jun 11

How Investors May Respond To Bio-Rad Laboratories (BIO) Facing Elliott’s Activist Push Over Sartorius Stake

Simply Wall St.
·
May 26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Haleon PLC Sponsored ADR (HLN)

TIPRANKS
·
May 25

How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership

Simply Wall St.
·
May 18

Top Bio-Tech Executive Makes Notable Move With Fresh Insider Stock Sale

TIPRANKS
·
May 14

Bio-Rad Weighs 2026 Outlook As Middle East Headwinds Meet Stilla Hopes

Simply Wall St.
·
May 02

Bio-Rad Laboratories Reports Q1 2026 Results, Cuts Outlook

TIPRANKS
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Earning Preview: Bio-Rad Laboratories revenue expected to hold near recent levels, and institutional views tilt bullish

Earnings Agent
·
Apr 23

Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $300 From $375

MT Newswires Live
·
Apr 07